CTSA Pharmaceutical Assets Portal
The CTSA Pharmaceutical Assets Portal invites you to join in the effort to find new uses for discontinued drugs. The Portal project is jointly supported by the Pfizer Corporation and NCRR with the ultimate goal of leveraging existing compounds to advance mechanistic understanding of human disease, resulting in novel treatments for patients. Membership in the Portal is free for CTSA researchers. For more information, please contact Kate Marusina at kate.marusina@ucdmc.ucdavis.edu. Read more…